These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2079995)

  • 41. Levamisole: adjunctive therapy in steroid dependent minimal change nephrotic children.
    Donia AF; Amer GM; Ahmed HA; Gazareen SH; Moustafa FE; Shoeib AA; Ismail AM; Khamis S; Sobh MA
    Pediatr Nephrol; 2002 May; 17(5):355-8. PubMed ID: 12042893
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Low-dose cyclosporin therapy combined with prednisolone for relapsing minimal change nephrotic syndrome in adults].
    Koike M; Honda K; Tsukada M; Itabashi M; Suzuki K; Uchida K; Nitta K; Yumura W; Nihei H
    Nihon Jinzo Gakkai Shi; 2002; 44(5):447-52. PubMed ID: 12216477
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Studies of a glomerular permeability factor in patients with minimal-change nephrotic syndrome.
    Yoshizawa N; Kusumi Y; Matsumoto K; Oshima S; Takeuchi A; Kawamura O; Kubota T; Kondo S; Niwa H
    Nephron; 1989; 51(3):370-6. PubMed ID: 2918948
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Increased interleukin-12 release from peripheral blood mononuclear cells in nephrotic phase of minimal change nephrotic syndrome.
    Lin CY; Chien JW
    Acta Paediatr Taiwan; 2004; 45(2):77-80. PubMed ID: 15335115
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hemostatic imbalance in active and quiescent ulcerative colitis.
    van Bodegraven AA; Schoorl M; Baak JP; Linskens RK; Bartels PC; Tuynman HA
    Am J Gastroenterol; 2001 Feb; 96(2):487-93. PubMed ID: 11232695
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Minimal-change nephrotic syndrome in adults treated with alternate-day steroids.
    Nair RB; Date A; Kirubakaran MG; Shastry JC
    Nephron; 1987; 47(3):209-10. PubMed ID: 3683690
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pulse cyclophosphamide inadequately suppresses reoccurrence of minimal change nephrotic syndrome in corticoid-dependent children.
    Donia AF; Gazareen SH; Ahmed HA; Moustafa FE; Shoeib AA; Ismail AM; Khamis S; Sobh MA
    Nephrol Dial Transplant; 2003 Oct; 18(10):2054-8. PubMed ID: 13679480
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Systemic lupus erythematosus in a patient with remitting minimal change nephrotic syndrome.
    Nishihara G; Nakamoto M; Yasunaga C; Takeda K; Matsuo K; Urabe M; Goya T; Sakemi T
    Clin Nephrol; 1997 Nov; 48(5):327-30. PubMed ID: 9403219
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Urotensin-II levels in children with minimal change nephrotic syndrome.
    Balat A; Pakir IH; Gok F; Anarat R; Sahinoz S
    Pediatr Nephrol; 2005 Jan; 20(1):42-5. PubMed ID: 15602665
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [A case of nephrotic syndrome associated with minimal renal amyloidosis--a four-year follow-up].
    Makibayashi K; Yanagita M; Kanatsu K
    Nihon Jinzo Gakkai Shi; 1997 Jul; 39(5):507-11. PubMed ID: 9283217
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Characteristics of lipid metabolism under different urinary protein excretion in children with primary nephrotic syndrome.
    Hu P; Lu L; Hu B; Du PF
    Scand J Clin Lab Invest; 2009; 69(6):680-6. PubMed ID: 19468931
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Isoelectric focusing and selectivity index in IgA nephrotic syndrome.
    Woo KT; Lau YK; Wong KS; Lee GS; Chin YM; Chiang GS; Lim CH
    Nephron; 1994; 67(4):408-13. PubMed ID: 7969672
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Minimal-change nephrotic syndrome associated with systemic lupus erythematosus.
    Makino H; Haramoto T; Shikata K; Ogura T; Ota Z
    Am J Nephrol; 1995; 15(5):439-41. PubMed ID: 7503146
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Concentration of three thrombin inhibitors in the nephrotic syndrome in adults.
    Rydzewski A; Myśliwiec M; Soszka J
    Nephron; 1986; 42(3):200-3. PubMed ID: 2418377
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Intravenous cyclophosphamide in steroid-resistant nephrotic syndrome.
    Bajpai A; Bagga A; Hari P; Dinda A; Srivastava RN
    Pediatr Nephrol; 2003 Apr; 18(4):351-6. PubMed ID: 12700961
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Elevated vascular endothelial growth factor levels in the urine of patients with minimal-change nephrotic syndrome.
    Matsumoto K; Kanmatsuse K
    Clin Nephrol; 2001 Apr; 55(4):269-74. PubMed ID: 11334311
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Intraglomerular deposition of coagulation-fibrinolysis factors and a platelet membrane antigen in various glomerular diseases.
    Deguchi F; Tomura S; Yoshiyama N; Takeuchi J
    Nephron; 1989; 51(3):377-83. PubMed ID: 2563903
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Lipoid nephrosis: changes in proteinemia and albuminemia after resolution of proteinuria].
    Bensman A; Vanille V; Feldmann D; Sinnassamy P; Brackman D
    Ann Pediatr (Paris); 1989 Mar; 36(3):208-10. PubMed ID: 2729843
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Effect of prednisolone and human albumin on protein excretion in nephrotic syndrome].
    LACHNIT V; REINHARDT F; TRETENHAHN W
    Med Klin; 1958 Sep; 53(39):1688-90. PubMed ID: 13589594
    [No Abstract]   [Full Text] [Related]  

  • 60. Antithrombin III (AT III) and fibrinogen levels in nephrotic syndrome in children.
    Elidrissy AT; Gader AM
    Haemostasis; 1985; 15(6):384-8. PubMed ID: 4076845
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.